Приказ основних података о документу

dc.creatorRoksandić Milenković, M.
dc.creatorKlisić, Aleksandra
dc.creatorCeriman, V.
dc.creatorKotur-Stevuljević, Jelena
dc.creatorSavić-Vujović, Katarina
dc.creatorMirkov, D.
dc.creatorGajić, M.
dc.creatorIlić, B.
dc.creatorDimić, N.
dc.creatorSamardžić, N.
dc.creatorJovanović, D.
dc.date.accessioned2022-06-08T09:41:57Z
dc.date.available2022-06-08T09:41:57Z
dc.date.issued2022
dc.identifier.issn1128-3602
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4171
dc.description.abstractObjective: The pathophysiological mechanisms of idiopathic pulmonary fibrosis (IPF) are not well elucidated. It is assumed that oxidative stress and inflammation are the key underlying culprits for its onset and progression. To gain deeper insight into these processes, we have evaluated several oxidative stress parameters, inflammation markers [i.e., high sensitivity C-reactive protein (hsCRP), serum amyloid A1 (SAA1)], soluble programmed cell death-ligand 1 (sPD-L1), and 25-hydroxyvitamin D [25(OH)D] in IPF patients. Patients and Methods: Biochemistry analyses were done in 30 consecutive IPF patients and 30 age and gender-matched healthy control group (CG). Results: IPF patients had significantly higher advanced oxidation protein products (p<0.001), pro-oxidant-antioxidant balance (p=0.010), total oxidative status (p<0.001), and ischemia modified albumin (p<0.001) compared to CG. Lower total antioxidant status and total sulfhydryl groups (tSGH) and significantly higher sPD-L1, hsCRP (p<0.001 for all), SAA1 proteins (p=0.014) and [25(OH)D] severe deficiency [11.0 (9.6-15.1) nmol/L] in IPF patients compared to CG were observed. Paraoxonase 1 activity and hsCRP level were lower, while tSHG and sPD-L1 were higher in IPF patients with more severe disease (i.e., II+III stage compared to I stage, p<0.05 for all). Conclusions: IPF patients are in a state of profound oxidative stress compared to healthy people. The inflammatory component of the disease was confirmed by higher hsCRP and SAA1, but lower [25(OH)D] in IPF than in healthy people. Also, higher levels of sPD-L1 in patients with IPF compared to healthy individuals suggest that sPD-L1 may have a significant role in immune response in IPF. © 2022 Verduci Editore s.r.l. All rights reserved.sr
dc.language.isoensr
dc.publisherVerduci Editore s.r.lsr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175046/RS//sr
dc.relationMinistry of Education, Science and Technological Development of Serbia, Project numbers III 43 007sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS//sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceEuropean Review for Medical and Pharmacological Sciencessr
dc.subjectIdiopathic pulmonary fibrosissr
dc.subjectInflammationsr
dc.subjectOxidative stresssr
dc.subjectSoluble programmed cell death-ligand 1sr
dc.titleOxidative stress and inflammation parameters-novel biomarkers for idiopathic pulmonary fibrosissr
dc.typearticlesr
dc.rights.licenseBY-NC-NDsr
dc.citation.volume26
dc.citation.issue3
dc.citation.spage927
dc.citation.epage934
dc.citation.rankM22
dc.identifier.wos000759707100022
dc.identifier.doi10.26355/eurrev_202202_28002
dc.identifier.scopus2-s2.0-85124999843
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/9865/Oxidative_stress_and_pub_2022.pdf
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу